These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9285557)

  • 1. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase.
    Agarwal ML; Agarwal A; Taylor WR; Wang ZQ; Wagner EF; Stark GR
    Oncogene; 1997 Aug; 15(9):1035-41. PubMed ID: 9285557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest.
    Wesierska-Gadek J; Schloffer D; Gueorguieva M; Uhl M; Skladanowski A
    Cancer Res; 2004 Jul; 64(13):4487-97. PubMed ID: 15231658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1.
    Lövborg H; Wojciechowski J; Larsson R; Wesierska-Gadek J
    Cancer Res; 2002 Aug; 62(15):4206-11. PubMed ID: 12154020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts.
    Huang LC; Clarkin KC; Wahl GM
    Cancer Res; 1996 Jul; 56(13):2940-4. PubMed ID: 8674045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
    BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective control of mitotic and post-mitotic checkpoints in poly(ADP-ribose) polymerase-1(-/-) fibroblasts after mitotic spindle disruption.
    Halappanavar SS; Shah GM
    Cell Cycle; 2004 Mar; 3(3):335-42. PubMed ID: 14726664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
    Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
    EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased resistance to anticancer therapy of mouse cells lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein.
    Wurzer G; Herceg Z; Wesierska-Gadek J
    Cancer Res; 2000 Aug; 60(15):4238-44. PubMed ID: 10945636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced stability of regularly spliced but not alternatively spliced p53 protein in PARP-deficient mouse fibroblasts.
    Wesierska-Gadek J; Wang ZQ; Schmid G
    Cancer Res; 1999 Jan; 59(1):28-34. PubMed ID: 9892179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation.
    Wieler S; Gagné JP; Vaziri H; Poirier GG; Benchimol S
    J Biol Chem; 2003 May; 278(21):18914-21. PubMed ID: 12642583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice.
    Conde C; Mark M; Oliver FJ; Huber A; de Murcia G; Ménissier-de Murcia J
    EMBO J; 2001 Jul; 20(13):3535-43. PubMed ID: 11432840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP-1 modifies the effectiveness of p53-mediated DNA damage response.
    Valenzuela MT; Guerrero R; Núñez MI; Ruiz De Almodóvar JM; Sarker M; de Murcia G; Oliver FJ
    Oncogene; 2002 Feb; 21(7):1108-16. PubMed ID: 11850828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parg deficiency confers radio-sensitization through enhanced cell death in mouse ES cells exposed to various forms of ionizing radiation.
    Shirai H; Fujimori H; Gunji A; Maeda D; Hirai T; Poetsch AR; Harada H; Yoshida T; Sasai K; Okayasu R; Masutani M
    Biochem Biophys Res Commun; 2013 May; 435(1):100-6. PubMed ID: 23624507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory expression of p73 in PARP-deficient mouse fibroblasts as response to a reduced level of regularly spliced wild-type p53 protein.
    Schmid G; Wang ZQ; Wesierska-Gadek J
    Biochem Biophys Res Commun; 1999 Feb; 255(2):399-405. PubMed ID: 10049720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential susceptibility of normal and PARP knock-out mouse fibroblasts to proteasome inhibitors.
    Wesierska-Gadek J; Bohrn E; Herceg Z; Wang ZQ; Wurzer G
    J Cell Biochem; 2000 Jun; 78(4):681-96. PubMed ID: 10861865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray-induced damage repair in exponentially growing and growth arrested confluent poly(adenosine diphosphate-ribose) polymerase-deficient V79 chinese hamster cell line.
    Chatterjee S; Berger NA
    Int J Oncol; 2000 Nov; 17(5):955-62. PubMed ID: 11029498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint.
    Wesierska-Gadek J; Schmid G
    J Cell Biochem; 2000 Sep; 80(1):85-103. PubMed ID: 11029756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite.
    Poonepalli A; Balakrishnan L; Khaw AK; Low GK; Jayapal M; Bhattacharjee RN; Akira S; Balajee AS; Hande MP
    Cancer Res; 2005 Dec; 65(23):10977-83. PubMed ID: 16322246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase-1 modulates interferon-gamma-inducible protein (IP)-10 expression in murine embryonic fibroblasts by stabilizing IP-10 mRNA.
    Galbis-Martínez M; Saenz L; Ramírez P; Parrilla P; Yélamos J
    Mol Immunol; 2010 Apr; 47(7-8):1492-9. PubMed ID: 20171739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.